[ad_1]
While the whole world still suffers from the emerging corona virus, experts race against time to find a cure and vaccine for the enemy of humanity that has so far infected more than 50 million people, and killed over a million, since it first appeared less than a year ago in China.
What is new today is a study by the University of Oxford, which announced that aspirin is the latest drug to be evaluated in a large-scale recovery trial, and found the use of the common corticosteroid “dexamethasone” in the treatment of Covid-19 cases, according to Politico.
And according to a press release on November 6, the properties of aspirin with anticoagulant, a 120-year-old, accessible drug, may help avoid complications from blood clots associated with COVID-19.
At this, daily medicine joins the list of more advanced treatments, such as Regeneron’s monoclonal antibodies, which have been reviewed by scientists in the UK as potential treatments for Corona infection.
“The fact that the drug is safe, inexpensive and widely available increases its appeal,” said Peter Horby of the University of Oxford, the principal investigator involved in the trial. “We are looking for drugs for Covid-19 that anyone can use immediately with any type.” A place in the world, ”adding:“ We don’t know if aspirin is such a drug, but we will.
It should be noted that the study will focus on patient deaths after 28 days, while assessing the length of hospital stay and the need for artificial respiration. According to the version published by the researchers, at least 2,000 infected patients should receive aspirin with their usual care.
It will likely be several months before a trial produces enough data to judge whether aspirin is of benefit to patients.
It is reported that Corona has so far infected 50,255,095 people and killed 1,256,123 worldwide.
Source link
